Anlon Healthcare Moves Beyond APIs with INR 5.38 Cr Acquisition of Remember India Health Links

Remember India Health Links will operate as a subsidiary, enabling tighter operational and strategic integration.

Gujarat-based Anlon Healthcare has approved the acquisition of a 63.98% stake in Remember India Health Links, Gujarat, for INR 5.38 Cr, marking a decisive step toward expanding beyond API manufacturing into finished dosage formulations and integrated pharmaceutical operations.

The company has traditionally operated in the active pharmaceutical ingredient (API) segment, which forms the backbone of drug manufacturing but limits direct engagement with end-product markets. By entering the formulations segment, companies like Anlon can gain closer access to market demand, regulatory filings, and branded or generic drug opportunities.

Under the terms of the agreement, Anlon will acquire 1.11 Cr equity shares, representing 63.98% ownership in Remember India Health Links, at a total consideration of INR 5.38 Cr. The transaction, structured as a cash deal, is expected to be completed within four to five months, subject to customary conditions.

Once finalized, the target company will operate as a subsidiary, enabling tighter operational and strategic integration.

Remember India Health Links, incorporated in December 2020, is engaged in manufacturing finished pharmaceutical products such as tablets and capsules. Its portfolio of more than 30 formulation dossiers presents a key asset for Anlon, offering immediate entry into regulated product development and commercialization pathways.

The acquisition is expected to strengthen Anlon’s positioning across multiple dimensions. Operationally, it enables the integration of manufacturing and quality control processes across APIs and finished products.

Financially, it opens up opportunities for improved margins and diversified income streams. Strategically, it allows the company to reposition itself from a backend supplier to a more visible pharmaceutical platform.

Moreover, the development indicates ongoing financial restructuring and balance sheet optimization as the company prepares for its next phase of growth.

Stay tuned for more such updates on Digital Health News